Steven Frank Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

BCRX Quotes by TradingView

Steven Frank is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 16,052 shares of BCRX, which is worth approximately $123,600. The most recent transaction as insider was on Aug 29, 2025, when has been sold 1,353 shares (Common Stock) at a price of $8.31 per share, resulting in proceeds of $11,243. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.1K
9.2% 3M change
n/a 12M change
Total Value Held $123,600

Steven Frank Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 29 2025
BUY
Grant, award, or other acquisition
$11,243 $8.31 p/Share
1,353 Added 7.77%
16,052 Common Stock
Jun 12 2025
BUY
Grant, award, or other acquisition
-
12,500 Added 45.96%
14,699 Common Stock
May 30 2025
BUY
Grant, award, or other acquisition
$3,579 $10.75 p/Share
333 Added 13.15%
2,199 Common Stock
May 02 2025
BUY
Grant, award, or other acquisition
-
1,866 Added 50.0%
1,866 Common Stock

Also insider at

PGEN
PRECIGEN, INC. Healthcare
Director
SF

Steven Frank

Director
Germantown, MD

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCRX